...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Prospective analysis of the pattern and risk for severe vital sign changes during percutaneous radiofrequency ablation of the liver under opioid analgesia.
【24h】

Prospective analysis of the pattern and risk for severe vital sign changes during percutaneous radiofrequency ablation of the liver under opioid analgesia.

机译:在阿片类药物镇痛下经皮射频消融肝过程中严重生命体征变化的模式和风险的前瞻性分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The aims of this study were to evaluate the pattern of vital sign changes and to elucidate significant risk factors for severe cardiovascular inhibition caused by percutaneous hepatic radiofrequency ablation (RFA). SUBJECTS AND METHODS: A total of 102 patients (male-to-female ratio, 73:29; age range, 35-85 years; mean age, 58.1 years) with 119 malignant hepatic tumors were enrolled and analyzed prospectively. The patients underwent percutaneous RFA with IV infusion of opioid analgesics. Changes in blood pressure (BP) and heart rate (HR) and the occurrence of significant cardiovascular inhibition (BP or HR < 70% of baseline) were monitored during the procedure. Respiratory rate and skin body temperature were recorded before and after the procedure. RESULTS: Whereas the mean BP was elevated (36%, 43/119) or depressed (36%, 43/119) with a similar frequency, the HR was predominantly depressed (56%, 66/119) during the procedure. The BP and HR were stable in only 18% cases (21/119), respectively. The respiratory rate showed no significant change (p = 0.521) after RFA; however, body temperature decreased (p < 0.001) after RFA. Although significant cardiovascular inhibition occurred in 41 cases (35%), all of the cases could be managed successfully and the technical success rate was 100% (119/119). Among the risk factors analyzed, old age (B = -0.003, p = 0.019) was significant for systolic BP depression, and contact of the RFA zone with the central portal vein (B = -0.096, p = 0.014) and female sex (B = -0.078, p = 0.033) were significant risk factors for HR depression as determined by multivariate analysis. CONCLUSION: Changes in BP and HR, especially bradycardia, are common during percutaneous RFA of hepatic lesions. Significant risk factors for severe cardiovascular inhibition include contact of the RFA zone with the branches of the central portal vein, old age, and female sex.
机译:目的:本研究旨在评估生命体征变化的模式,并阐明经皮肝射频消融术(RFA)引起严重心血管抑制的重要危险因素。研究对象和方法:前瞻性分析了102例119例恶性肝肿瘤患者(男女比例73:29;年龄范围35-85岁;平均年龄58.1岁)。患者接受经皮RFA静脉输注阿片类镇痛药。在手术过程中监测血压(BP)和心率(HR)的变化以及显着的心血管抑制作用(BP或HR <基线的70%)。记录手术前后的呼吸频率和皮肤体温。结果:尽管平均血压以相似的频率升高(36%,43/119)或降低(36%,43/119),但在此过程中,HR显着降低(56%,66/119)。血压和心率分别仅在18%的情况下稳定(21/119)。 RFA后呼吸频率无明显变化(p = 0.521);但是,RFA后体温下降(p <0.001)。尽管有41例(35%)发生了明显的心血管抑制,但所有病例均可成功治疗,技术成功率为100%(119/119)。在分析的危险因素中,老年(B = -0.003,p = 0.019)对于收缩压降低,RFA区与门静脉中央的接触(B = -0.096,p = 0.014)和女性( B = -0.078,p = 0.033)是通过多因素分析确定的HR降低的重要危险因素。结论:在经皮RFA肝损伤期间,血压和心率的改变,尤其是心动过缓是常见的。严重抑制心血管的重要危险因素包括RFA区与门静脉中央分支的接触,老年和女性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号